Listen to the article
The trust between parents and healthcare providers is critical when it comes to childhood vaccinations, according to medical professionals who cite both research and personal experience in navigating these important decisions.
Dr. Mona Amin, a board-certified pediatrician who has counseled hundreds of families through vaccine decisions, recently shared her own experience that mirrors what many parents face – the emotional challenge of making vaccination choices for their children, even with medical training.
“When it was time to vaccinate my own baby, I hesitated,” Dr. Amin reveals. Her son was born with a stroke and spent his first days in the NICU on anti-seizure medication. “I remember lying awake at night, staring at the ceiling, wondering what choice was safest. In that moment, I didn’t feel like a clinician. I felt like a mom, scared, overwhelmed, and trying to protect my child.”
Dr. Amin ultimately chose to vaccinate her son, who responded well, but she acknowledges that her fears didn’t disappear overnight. Her experience highlights a critical point for parents: questioning vaccine schedules or worrying about side effects doesn’t make someone “anti-vaccine” – it makes them concerned parents seeking information.
Public health experts point out that the infant vaccine schedule, which can appear crowded in the first 18 months, is carefully designed to protect babies when they’re most vulnerable. Vaccines like DTaP (diphtheria, tetanus, pertussis), Hib (Haemophilus influenzae type b), pneumococcal, and rotavirus are administered early because these infections pose serious risks to infants.
“The timing isn’t random,” explains Dr. Amin. “Vaccines are given at ages when the immune system can mount a strong, lasting response.” According to the Centers for Disease Control and Prevention (CDC), delaying vaccines doesn’t improve safety but often leaves children unprotected during critical developmental windows.
The development and monitoring of vaccines involves multiple layers of safety protocols. Before approval, vaccines undergo years of research and testing, starting with discovery and pre-clinical testing, followed by three phases of clinical trials. Phase 1 evaluates safety in small groups, Phase 2 examines dosing and immune response in hundreds of participants, and Phase 3 involves thousands to confirm safety and effectiveness across larger populations.
After FDA approval, ongoing surveillance continues through systems including the Vaccine Adverse Event Reporting System (VAERS), the Vaccine Safety Datalink, and the Clinical Immunization Safety Assessment Project, which collectively track and investigate potential side effects nationwide.
Despite this extensive testing and monitoring, misinformation about vaccines persists. Dr. Amin addresses three common myths that continue to cause parental concern. The first involves a supposed link between vaccines and Sudden Infant Death Syndrome (SIDS). Research, including a 2015 meta-analysis published in BMC Pediatrics, found no increased risk of SIDS from vaccines. In fact, vaccinated infants, particularly those receiving DTaP, showed a lower SIDS risk compared to unvaccinated children.
The second myth connecting vaccines to autism originated from a discredited 1998 study by Andrew Wakefield, which was retracted due to manipulated data and ethical violations. Numerous large-scale studies have since found no link between vaccines and autism.
The third misconception suggests vaccines cause allergies, eczema, or asthma. Multiple studies have found no increased risk of these conditions following vaccination. Ironically, some infections that vaccines prevent, including RSV and whooping cough, are associated with higher asthma risk later in life.
Parents frequently ask about spacing out vaccines, whether multiple vaccines overwhelm a baby’s immune system, and whether vaccines are necessary for children not in daycare. Medical experts note that while spacing out vaccines is technically possible, it leaves children vulnerable longer without evidence of enhanced safety. They also emphasize that a baby’s immune system routinely handles thousands of challenges daily, making vaccines a minimal additional burden by comparison.
“You don’t need to have every answer right away. And you don’t need to make decisions rooted in fear,” Dr. Amin concludes. “Vaccines are one of the most effective tools we have to protect children during their most vulnerable years. But questions are part of the process, and they deserve thoughtful, evidence-based answers.”
Fact Checker
Verify the accuracy of this article using The Disinformation Commission analysis and real-time sources.


9 Comments
Exploration results look promising, but permitting will be the key risk.
If AISC keeps dropping, this becomes investable for me.
Uranium names keep pushing higher—supply still tight into 2026.
Good point. Watching costs and grades closely.
The cost guidance is better than expected. If they deliver, the stock could rerate.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
Uranium names keep pushing higher—supply still tight into 2026.
Exploration results look promising, but permitting will be the key risk.